Experiment 79101

Worktypes

PHARMACOLOGY OF COMPOUND - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGSANTICANCER AND/OR CYTOTOXICITY MARKER CODEPATENT DESCRIBED

Compounds isolated

ADRIAMYCIN

Alerts

BIOLOGICAL ACTIVITY REPORTED HAS BEEN PATENTED.A MIXTURE OF PURE COMPOUNDS WAS USED TO OBTAIN THE REPORTED EFFECT.DATA INCOMPLETE - DERIVED FROM AN ABSTRACT.

Details

PropertyValue
Pharmacology
ANTITUMOR ACTIVITY
Administration routeROUTE NOT GIVEN
OrganismEmpty organism
CitationHORI,R: OKUMURA,K: KUNIMASA,J:. (1984). SLOW-RELEASE ANTICANCER PHARMACEUTICALS.. ()
Amount utilized
Compound isolated
DiseaseA MIXTURE OF DOXORUBICIN AND CARRAGEENAN WAS USED TO MAKE A SUSTAINED RELEASE PREPARATION FOR USE IN CANCER THERAPY.
Dose amount0.2 MG
Number2
Qualitative resultACTIVE
AnimalRAT
Per unitANIMAL
Dose expressionDOSE